EISAI CORPORATION OF NORTH AMERICA

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2009–2010

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2010	—	4	2
2009	—	10	2

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
FOLEY HOAG LLP	—	10
WILLIAMS AND JENSEN, PLLC	—	4

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
Centers For Medicare and Medicaid Services (CMS)	6
SENATE	5
HOUSE OF REPRESENTATIVES	4
Health & Human Services, Dept of (HHS)	2

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	13
Copyright/Patent/Trademark	Copyright/Patent/Trademark	9
Medicare/Medicaid	Medicare/Medicaid	7

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

S. 369111th Congress

Preserve Access to Affordable Generics Act

2010 · second_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Preserve to Affordable Generics Act, S. 369 Patent Reform Act S. 515

Client expense: — · Firm income: $45,000

Matched citations: S. 369

S. 515111th Congress

Patent Reform Act of 2009

2010 · second_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Preserve to Affordable Generics Act, S. 369 Patent Reform Act S. 515

Client expense: — · Firm income: $45,000

Matched citations: S. 515

H.R. 3590110th Congress

American Middle Class Tax (AMT) Relief Act of 2007

2010 · first_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)

Client expense: — · Firm income: $45,000

Matched citations: H.R. 3590

H.R. 4872110th Congress

To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.

2010 · first_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)

Client expense: — · Firm income: $45,000

Matched citations: H.R. 4872

Show 21 more cited filings

S. 369111th Congress

Preserve Access to Affordable Generics Act

2010 · first_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Preserve Access to Affordable Generics Act, S. 369 Patent Reform Act S. 515

Client expense: — · Firm income: $45,000

Matched citations: S. 369

S. 515111th Congress

Patent Reform Act of 2009

2010 · first_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Preserve Access to Affordable Generics Act, S. 369 Patent Reform Act S. 515

Client expense: — · Firm income: $45,000

Matched citations: S. 515

H.R. 3590110th Congress

American Middle Class Tax (AMT) Relief Act of 2007

2010 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; and H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act.

Client expense: — · Firm income: —

Matched citations: H.R. 3590

H.R. 3962110th Congress

Superfund Polluter Pays Act

2010 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; and H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act.

Client expense: — · Firm income: —

Matched citations: H.R. 3962

H.R. 1706111th Congress

Protecting Consumer Access to Generic Drugs Act of 2009

2010 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; and H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act.

Client expense: — · Firm income: —

Matched citations: H.R. 1706

S. 369111th Congress

Preserve Access to Affordable Generics Act

2010 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; and H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act.

Client expense: — · Firm income: —

Matched citations: S. 369

H.R. 3590110th Congress

American Middle Class Tax (AMT) Relief Act of 2007

2009 · fourth_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.

Client expense: — · Firm income: $66,000

Matched citations: H.R.3590

H.R. 3962110th Congress

Superfund Polluter Pays Act

2009 · fourth_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.

Client expense: — · Firm income: $66,000

Matched citations: HR 3962

H.R. 1427111th Congress

Promoting Innovation and Access to Life-Saving Medicine Act

2009 · fourth_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.

Client expense: — · Firm income: $66,000

Matched citations: H.R.1427

H.R. 1548111th Congress

Pathway for Biosimilars Act

2009 · fourth_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.

Client expense: — · Firm income: $66,000

Matched citations: H.R.1548

S. 1213111th Congress

Patient-Centered Outcomes Research Act of 2009

2009 · fourth_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.

Client expense: — · Firm income: $66,000

Matched citations: S.1213

S. 369111th Congress

Preserve Access to Affordable Generics Act

2009 · fourth_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Preserve Access to Affordable Generics Act - S.369 Patent Reform Act - S.515

Client expense: — · Firm income: $66,000

Matched citations: S.369

S. 515111th Congress

Patent Reform Act of 2009

2009 · fourth_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Preserve Access to Affordable Generics Act - S.369 Patent Reform Act - S.515

Client expense: — · Firm income: $66,000

Matched citations: S.515

H.R. 3590110th Congress

American Middle Class Tax (AMT) Relief Act of 2007

2009 · fourth_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.

Client expense: — · Firm income: $66,000

Matched citations: H.R.3590

H.R. 3962110th Congress

Superfund Polluter Pays Act

2009 · fourth_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.

Client expense: — · Firm income: $66,000

Matched citations: HR 3962

H.R. 1427111th Congress

Promoting Innovation and Access to Life-Saving Medicine Act

2009 · fourth_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.

Client expense: — · Firm income: $66,000

Matched citations: H.R.1427

H.R. 1548111th Congress

Pathway for Biosimilars Act

2009 · fourth_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.

Client expense: — · Firm income: $66,000

Matched citations: H.R.1548

S. 1213111th Congress

Patient-Centered Outcomes Research Act of 2009

2009 · fourth_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.

Client expense: — · Firm income: $66,000

Matched citations: S.1213

S. 369111th Congress

Preserve Access to Affordable Generics Act

2009 · fourth_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Preserve Access to Affordable Generics Act - S.369 Patent Reform Act - S.515

Client expense: — · Firm income: $66,000

Matched citations: S.369

S. 515111th Congress

Patent Reform Act of 2009

2009 · fourth_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Preserve Access to Affordable Generics Act - S.369 Patent Reform Act - S.515

Client expense: — · Firm income: $66,000

Matched citations: S.515

H.R. 3590110th Congress

American Middle Class Tax (AMT) Relief Act of 2007

2009 · fourth_quarter · Firm: FOLEY HOAG LLP

Open original LDA filing ↗

Cited source text and reported amounts

Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.

Client expense: — · Firm income: $66,000

Matched citations: H.R.3590

Source: Senate LDA

EISAI CORPORATION OF NORTH AMERICA — Lobbying Disclosure | Poliscope